Histone Methyltransferase G9a-Promoted Progression of Hepatocellular Carcinoma Is Targeted by Liver-Specific Hsa-miR-122.

Cancers (Basel) · 2021 · PMC8157135 · PMID 34069116

Europe PMC DOI

hedged sentences

0.0507

closest p · 1.0× alpha

0.1080

boldest claim

The sentences

showed a trendp = 0.0507so close (0.05 < p ≤ 0.1)

We observed that G9a protein expression levels showed a trend of correlating with cirrhosis ( p = 0.0507), but with no other clinical characteristics in our recruited HCC cohort.

also in 53,322 other papers

did not reach statistical significancep = 0.08so close (0.05 < p ≤ 0.1)

Our clinical assessments suggested that G9a is likely to be an independent prognostic marker of HCC, albeit this result did not reach statistical significance ( p = 0.08).

also in 111,027 other papers

a slight trendp = 0.108not close (p > 0.1)

Elevated miR-122 only showed a slight trend toward favorable survival rates ( p = 0.108 for OS and p = 0.036 for DFS) ( Figure 6 B).

also in 4,078 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.